The complex pathophysiology of acquired aplastic anaemia.

Area of Science:

• Hematology
• Immunology
• Genetics

Background:

• Acquired aplastic anaemia (aAA) is characterized by immune-mediated destruction of hematopoietic stem/progenitor cells (HSPCs).
• Dysregulation of various immune cells, including CD8(+) cytotoxic T cells, CD4(+) T cells (Th1, Th2, Treg, Th17), NK cells, and NKT cells, contributes to HSPC apoptosis.
• Abnormal cytokine production (IFN-γ, TNF-α, TGF-β) is a defining feature of severe aAA, inducing programmed cell death of HSPCs.

Purpose of the Study:

• To elucidate the immunological and genetic mechanisms underlying acquired aplastic anaemia.
• To understand the role of immune cell dysregulation and cytokine abnormalities in hematopoietic stem/progenitor cell destruction.
• To explore potential genetic predispositions and intrinsic cell deficits in the development of bone marrow failure.

Main Methods:

• Review of existing literature on the pathophysiology of acquired aplastic anaemia.
• Analysis of immune cell populations and cytokine profiles in patients with severe aAA.
• Examination of genetic polymorphisms in cytokine genes (TGF-β, IFN-γ, TNF-α) and human leucocyte antigen (HLA) alleles.
• Investigation of autoantibody presence and potential autoantigens.
• Assessment of genetic and molecular evidence for intrinsic/secondary deficits in stem cells.

Main Results:

• Immune-mediated destruction of HSPCs is central to aAA pathophysiology.
• Dysregulated T cells, NK cells, and abnormal cytokine production (IFN-γ, TNF-α, TGF-β) induce HSPC apoptosis.
• Genetic variations in TGF-β, IFN-γ, TNF-α, and HLA alleles may increase susceptibility to immune-mediated HSPC killing or ineffective hematopoiesis.
• Autoantibodies are frequently detected, though inciting autoantigens remain unidentified.
• Emerging evidence suggests intrinsic or secondary deficits in HSPCs and bone marrow mesenchymal stem cells contribute to bone marrow failure.

Conclusions:

• Acquired aplastic anaemia is driven by immune attack on hematopoietic stem/progenitor cells, mediated by various immune cells and cytokines.
• Genetic factors and potential intrinsic stem cell defects likely play a role in the pathogenesis of bone marrow failure.
• Further research is needed to identify autoantigens and fully elucidate the interplay between genetic predisposition and immune dysregulation in aAA.